BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36805631)

  • 21. Clinicopathological factors influencing the number of stages of Mohs surgery for basal cell carcinoma.
    Calvão J; Pinho A; Brinca A; Vieira R
    An Bras Dermatol; 2022; 97(3):291-297. PubMed ID: 35379511
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recurrence of periocular basal cell carcinoma and squamous cell carcinoma after Mohs micrographic surgery: a retrospective cohort study.
    Weesie F; Naus NC; Vasilic D; Hollestein LM; van den Bos RR; Wakkee M
    Br J Dermatol; 2019 May; 180(5):1176-1182. PubMed ID: 30536656
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Misclassification of Aggressive Basal Cell Carcinoma Subtypes and Implications for Management.
    Moon D; Randall G; Higgins S; Sutton AV; Wysong A
    Dermatol Surg; 2021 May; 47(5):593-598. PubMed ID: 33905389
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristics of Superficial Basal Cell Carcinomas Containing More Aggressive Subtypes on Final Histopathologic Diagnosis.
    Sohn GK; Keniston K; Kannan S; Hinds B; Jian SIB
    J Drugs Dermatol; 2021 Aug; 20(8):874-879. PubMed ID: 34397195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Basal cell carcinoma of the head region: therapeutical results of 350 lesions treated with Mohs micrographic surgery.
    Veronese F; Farinelli P; Zavattaro E; Zuccoli R; Bonvini D; Leigheb G; Colombo E
    J Eur Acad Dermatol Venereol; 2012 Jul; 26(7):838-43. PubMed ID: 21707774
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Basosquamous carcinoma and metatypical basal cell carcinoma: a review of treatment with Mohs micrographic surgery.
    Allen KJ; Cappel MA; Killian JM; Brewer JD
    Int J Dermatol; 2014 Nov; 53(11):1395-403. PubMed ID: 24961583
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors for complicated Mohs surgery in the South Sweden Mohs Cohort.
    Nätterdahl C; Kappelin J; Persson B; Lundqvist K; Ahnlide I; Saleh K; Ingvar Å
    J Eur Acad Dermatol Venereol; 2022 Jul; 36(7):1113-1117. PubMed ID: 35366359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Additional review of Mohs slides to optimize Mohs micrographic surgery.
    van Lee CB; Graafland B; Koljenović S; Neumann HA; Nasserinejad K; Nijsten TE; van den Bos RR; Munte K
    Br J Dermatol; 2015 Jul; 173(1):123-7. PubMed ID: 25708878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differences of Mohs micrographic surgery in basal cell carcinoma versus squamous cell carcinoma.
    Delgado Jiménez Y; Camarero-Mulas C; Sanmartín-Jiménez O; Garcés JR; Rodríguez-Prieto MÃ; Alonso-Alonso T; Miñano Medrano R; López-Estebaranz JL; de Eusebio Murillo E; Redondo P; Ciudad-Blanco C; Toll A; Artola Igarza JL; Allende Markixana I; Suarez Fernández R; Alfaro Rubio A; Alonso Pacheco ML; Vázquez-Veiga H; de la Cueva Dobao P; Ruiz-Salas V; Vilarrasa E; Barchino L; Morales-Gordillo V; Ocerin-Guerra I; Navarro Tejedor R; Hueso L; Mayor Arenal M; Seoane-Pose MJ; Cano-Martinez N; Garcia-Doval I; Descalzo MA;
    Int J Dermatol; 2018 Nov; 57(11):1375-1381. PubMed ID: 30246444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-Melanoma Skin Cancer Tumor's Characteristics and Histologic Subtype as a Predictor for Subclinical Spread and Number of Mohs Stages required to Achieve Tumor-Free Margins.
    Santos-Arroyo A; Carrasquillo OY; Cardona R; Sánchez JL; Valentín-Nogueras S
    P R Health Sci J; 2019 Mar; 38(1):40-45. PubMed ID: 30924914
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Formalin-fixed tissue Mohs surgery (slow Mohs) for basal cell carcinoma: 5-year follow-up data.
    Lawrence CM; Haniffa M; Dahl MG
    Br J Dermatol; 2009 Mar; 160(3):573-80. PubMed ID: 19210500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Imiquimod 5% cream as pretreatment of Mohs micrographic surgery for nodular basal cell carcinoma in the face: a prospective randomized controlled study.
    van der Geer S; Martens J; van Roij J; Brand E; Ostertag JU; Verhaegh ME; Neumann HA; Krekels GA
    Br J Dermatol; 2012 Jul; 167(1):110-5. PubMed ID: 22385074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reliability of skin biopsies in determining accurate tumor margins: a retrospective study after Mohs micrographic surgery.
    Koslosky CL; El Tal AK; Workman B; Tamim H; Durance MC; Mehregan DA
    Dermatol Surg; 2014 Sep; 40(9):964-70. PubMed ID: 25099294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Duplicitous growth of infiltrative basal cell carcinoma: Analysis of clinically undetected tumor extent in a paired case-control study.
    Hendrix JD; Parlette HL
    Dermatol Surg; 1996 Jun; 22(6):535-9. PubMed ID: 8646468
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Previous therapy and the recurrence rate of basal cell carcinoma after Mohs surgery: a meta-analysis.
    Sooksamran A; Pichai P; Suphannaphong M; Singthong S
    Arch Dermatol Res; 2023 Aug; 315(6):1747-1754. PubMed ID: 36847828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surgical excision versus Mohs' micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years' follow-up.
    Mosterd K; Krekels GA; Nieman FH; Ostertag JU; Essers BA; Dirksen CD; Steijlen PM; Vermeulen A; Neumann H; Kelleners-Smeets NW
    Lancet Oncol; 2008 Dec; 9(12):1149-56. PubMed ID: 19010733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mohs micrographic surgery for the management of nonmelanoma skin cancers.
    Cumberland L; Dana A; Liegeois N
    Facial Plast Surg Clin North Am; 2009 Aug; 17(3):325-35. PubMed ID: 19698914
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation of histologic subtypes of primary basal cell carcinoma and number of Mohs stages required to achieve a tumor-free plane.
    Orengo IF; Salasche SJ; Fewkes J; Khan J; Thornby J; Rubin F
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 1):395-7. PubMed ID: 9308552
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomized comparison of Mohs micrographic surgery and surgical excision for small nodular basal cell carcinoma: tissue-sparing outcome.
    Muller FM; Dawe RS; Moseley H; Fleming CJ
    Dermatol Surg; 2009 Sep; 35(9):1349-54. PubMed ID: 19500127
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surgical margin marking for high-risk basal cell carcinomas of the cephalic region: a single-centre experience.
    Cecchi R; Bartoli L; Brunetti L; Pavesi M; Rapicano V
    G Ital Dermatol Venereol; 2011 Apr; 146(2):79-84. PubMed ID: 21505392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.